559P Neratinib in HER2-mutant, Recurrent/metastatic Cervical Cancer (R/M CC): Updated Findings from the Phase 2 SUMMIT Basket Trial
ANNALS OF ONCOLOGY(2022)
Key words
HER2
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined